Medicure Stock EBITDA
| MPH Stock | CAD 0.89 0.14 18.67% |
Medicure fundamentals help investors to digest information that contributes to Medicure's financial success or failures. It also enables traders to predict the movement of Medicure Stock. The fundamental analysis module provides a way to measure Medicure's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medicure stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | 1.5 M | 1.6 M |
Medicure | EBITDA |
Medicure Company EBITDA Analysis
Medicure's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Medicure EBITDA | 1.32 M |
Most of Medicure's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medicure is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Medicure EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Medicure is extremely important. It helps to project a fair market value of Medicure Stock properly, considering its historical fundamentals such as EBITDA. Since Medicure's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Medicure's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Medicure's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Medicure Ebitda
Ebitda |
|
According to the company disclosure, Medicure reported earnings before interest,tax, depreciation and amortization of 1.32 M. This is 99.85% lower than that of the Pharmaceuticals sector and 98.69% lower than that of the Health Care industry. The ebitda for all Canada stocks is 99.97% higher than that of the company.
Medicure EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medicure's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medicure could also be used in its relative valuation, which is a method of valuing Medicure by comparing valuation metrics of similar companies.Medicure is currently under evaluation in ebitda category among its peers.
Medicure Current Valuation Drivers
We derive many important indicators used in calculating different scores of Medicure from analyzing Medicure's financial statements. These drivers represent accounts that assess Medicure's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Medicure's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 12.7M | 9.4M | 10.4M | 14.6M | 13.1M | 22.6M | |
| Enterprise Value | 11.4M | 6.9M | 6.3M | 8.8M | 7.9M | 7.5M |
Medicure Fundamentals
| Return On Equity | -0.0972 | ||||
| Return On Asset | -0.0836 | ||||
| Profit Margin | (0.1) % | ||||
| Operating Margin | (0.22) % | ||||
| Current Valuation | 5.32 M | ||||
| Shares Outstanding | 10.44 M | ||||
| Shares Owned By Insiders | 26.67 % | ||||
| Shares Owned By Institutions | 23.09 % | ||||
| Number Of Shares Shorted | 3.88 K | ||||
| Price To Earning | 22.88 X | ||||
| Price To Book | 0.46 X | ||||
| Price To Sales | 0.44 X | ||||
| Revenue | 21.69 M | ||||
| Gross Profit | 12.01 M | ||||
| EBITDA | 1.32 M | ||||
| Net Income | (922 K) | ||||
| Cash And Equivalents | 45.7 M | ||||
| Cash Per Share | 3.07 X | ||||
| Total Debt | 544 K | ||||
| Debt To Equity | 0.70 % | ||||
| Current Ratio | 4.71 X | ||||
| Book Value Per Share | 1.92 X | ||||
| Cash Flow From Operations | 2.08 M | ||||
| Short Ratio | 1.44 X | ||||
| Earnings Per Share | (0.20) X | ||||
| Target Price | 2.8 | ||||
| Beta | 0.73 | ||||
| Market Capitalization | 9.29 M | ||||
| Total Asset | 28.06 M | ||||
| Retained Earnings | (65.85 M) | ||||
| Working Capital | 7.27 M | ||||
| Net Asset | 28.06 M |
About Medicure Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medicure's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medicure using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medicure based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Medicure Stock Analysis
When running Medicure's price analysis, check to measure Medicure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicure is operating at the current time. Most of Medicure's value examination focuses on studying past and present price action to predict the probability of Medicure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicure's price. Additionally, you may evaluate how the addition of Medicure to your portfolios can decrease your overall portfolio volatility.